# STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency

> **NCT00263237** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 10 (—)

## Conditions studied

- Common Variable Immunodeficiency

## Interventions

- **DRUG:** STA-5326

## Key facts

- **NCT ID:** NCT00263237
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12-02
- **Primary completion:** —
- **Final completion:** 2008-07-23
- **Target enrollment:** 10 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00263237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00263237, "STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00263237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*